EPO and anemia: Thesefactors may be the cause of increased cardiovascular risk and all-cause death.Fifth, studies indicated that the use of angiotensin-converting enzyme (ACE) inhibitors can depress the synthesisof erythropoietin [29], which can aggravate anemia.